Edurant 2.5 mg
Edurant 2.5 mg is a medicine authorised by Swissmedic under authorisation number 69726. The authorisation holder is Janssen-Cilag AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 21 May 2025 and the authorisation is limited until 20 May 2030. ATC code J05AG05 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 69726 |
|---|---|
| Name | Edurant 2.5 mg |
| Full name | Edurant 2.5 mg, Tabletten zur Herstellung einer Suspension zum Einnehmen |
| Authorisation holder | Janssen-Cilag AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AG05 |
| First authorisation | 21 May 2025 |
| Authorisation validity | 20 May 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Edurant 2.5 mg, Tabletten zur Herstellung einer Suspension zum Einnehmen | A | 21 May 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 90 | Tablette(n) | J05AG05 | 08.03.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Edurant 2.5 mg authorised in Switzerland?
Yes. Edurant 2.5 mg is authorised by Swissmedic under authorisation number 69726, data as of 01 September 2026. The authorisation is limited until 20 May 2030.
Which dispensing category does Edurant 2.5 mg have?
Edurant 2.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Edurant 2.5 mg?
The authorisation holder is Janssen-Cilag AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.